Royal Brompton Hospital Private Patients Centre has recently launched a rapid diagnostic
service offering a wide range of tests either on the same day or at very short
notice. The tests cover a full range of
heart and lung medical conditions, giving private patients direct access to the
hospital’s state-of-the-art equipment and world renowned medical expertise at
very short notice.
David Shrimpton, Managing Director at Royal
Brompton Private Patients Centre, comments “The service is very quick and
extremely flexible – patients can either refer themselves or be referred by
their GP, and the costs for many will be covered by private medical insurance.”
The hospital offers same-day or next-day
appointments to speed up the diagnostic process and give patients peace of
mind. If a range of tests are needed these can all be done during the same
visit, with the results being available on the same day in most cases.
Tests available for same-day appointments:
- Electrocardiogram (ECG)
- Chest X-ray
- 24-hour, 48-hour and 72-hour holter monitoring (ECG tape)
- Trans-telephonic event recorders (King of Hearts)
- 24-hour blood pressure monitor
- Nuclear medicine scans including myocardial perfusion scan (provided the patient
has had no caffeine for 24 hours)
- Exercise stress test
- A range of blood tests
Tests available at one or two days notice:
- Complex echocardiogram including stress
- CT scanning with a 64-slice CT scanner or the advanced Dual Source Flash
- Cardiac magnetic resonance (CMR)
- Bone density scan
- Lung function tests
- Single and dual chamber pacemaker and defibrillator follow-up (pacing check)
The hospital is providing GPs with a
dedicated phoneline to make the booking process as quick as possible. The GPs’
line is 020 7351 8793. Patients can refer themselves by phoning 020 7351 8830.
Appointments are available Monday to Friday
between 9am and 8pm (5pm on Friday).
For more information about Royal Brompton
Hospital’s Rapid Diagnostic Service, please visit: www.rapiddiagnosticservice.com.
Private cardiology treatment news: 10 May 2012